Medifast, Inc. MED
NYSE
| 09/30/2026 | 06/30/2026 | ||||
|---|---|---|---|---|---|
| Revenue | -- | 0.45% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | 0.45% | |||
| Cost of Revenue | -- | -5.35% | |||
| Gross Profit | -- | 3.17% | |||
| SG&A Expenses | -- | 2.83% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -- | -1.00% | |||
| Operating Income | -- | 21.03% | |||
| Income Before Tax | -- | -54.10% | |||
| Income Tax Expenses | -- | -39.78% | |||
| Earnings from Continuing Operations | -- | -46.09% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -- | -46.09% | |||
| EBIT | -- | 21.03% | |||
| EBITDA | -- | 55.86% | |||
| EPS Basic | -462.54% | -44.40% | |||
| Normalized Basic EPS | -493.75% | 27.60% | |||
| EPS Diluted | -460.71% | -45.23% | |||
| Normalized Diluted EPS | -493.75% | 27.60% | |||
| Average Basic Shares Outstanding | 0.41% | 1.17% | |||
| Average Diluted Shares Outstanding | 0.41% | 1.17% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | 1.00% | 0.35% | |||